Cartesian Therapeutics, Inc. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Cartesian Therapeutics, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-06-30 was $0.00.
- Cartesian Therapeutics, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-03-31 was $2.88M.
- Cartesian Therapeutics, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2016-12-31 was $0.00.
- Cartesian Therapeutics, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2016-09-30 was $284.10M.
- Cartesian Therapeutics, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2016 was $142.05M.
- Cartesian Therapeutics, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2014 was $1.46M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2024-06-30 | $0.00 10-Q · filed 2025-11-06 | |
| 2024-03-31 | $2.88M 10-Q · filed 2024-11-07 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $142.05M 10-K · filed 2019-03-15 |
| 2016-09-30 | $284.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | |
| 2014-12-31 | $1.46M 10-K · filed 2017-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |